| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |